메뉴 건너뛰기




Volumn 52, Issue 4, 2013, Pages 718-726

The paradoxical effects of tnf inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis

Author keywords

Ankylosing spondylitis; BMD; SASSS; Syndesmophyte; TNF inhibitor

Indexed keywords

ADALIMUMAB; BISPHOSPHONIC ACID DERIVATIVE; ETANERCEPT; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT;

EID: 84875608186     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes364     Document Type: Article
Times cited : (39)

References (32)
  • 1
    • 0025265924 scopus 로고
    • Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis
    • Ralston SH, Urquhart GD, Brzeski M, Sturrock RD. Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ 1990;300: 563-5.
    • (1990) BMJ , vol.300 , pp. 563-565
    • Ralston, S.H.1    Urquhart, G.D.2    Brzeski, M.3    Sturrock, R.D.4
  • 3
    • 79953306817 scopus 로고    scopus 로고
    • Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis
    • Confavreux CB, Chapurlat RD. Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis. Osteoporosis Int 2011;22:1023-36.
    • (2011) Osteoporosis Int , vol.22 , pp. 1023-1036
    • Confavreux, C.B.1    Chapurlat, R.D.2
  • 4
    • 2342658406 scopus 로고    scopus 로고
    • Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled 52-week trial
    • Keystone EC, Kavanaugh AF, Sharp JT et al. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 2004;50:1400-11.
    • (2004) Arthritis Rheum , vol.50 , pp. 1400-1411
    • Keystone, E.C.1    Kavanaugh, A.F.2    Sharp, J.T.3
  • 5
    • 31044442965 scopus 로고    scopus 로고
    • The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
    • Breedveld FC, Weisman MH, Kavanaugh AF et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006;54:26-37.
    • (2006) Arthritis Rheum , vol.54 , pp. 26-37
    • Breedveld, F.C.1    Weisman, M.H.2    Kavanaugh, A.F.3
  • 6
    • 67549140328 scopus 로고    scopus 로고
    • Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy
    • van der Heijde D, Burmester G, Melo-Gomes J et al. Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy. Ann Rheum Dis 2009;68:1113-8.
    • (2009) Ann Rheum Dis , vol.68 , pp. 1113-1118
    • van der Heijde, D.1    Burmester, G.2    Melo-Gomes, J.3
  • 7
    • 33749150667 scopus 로고    scopus 로고
    • Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis
    • Vis M, Havaardsholm EA, Haugeberg G et al. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 2006; 65:1495-9.
    • (2006) Ann Rheum Dis , vol.65 , pp. 1495-1499
    • Vis, M.1    Havaardsholm, E.A.2    Haugeberg, G.3
  • 8
    • 0042072982 scopus 로고    scopus 로고
    • Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial
    • Braun J, Brandt J, Listing J et al. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial. Arthritis Rheum 2003;48:2224-33.
    • (2003) Arthritis Rheum , vol.48 , pp. 2224-2233
    • Braun, J.1    Brandt, J.2    Listing, J.3
  • 9
    • 23644459274 scopus 로고    scopus 로고
    • Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks
    • Davis JC, van der Heijde DM, Braun J et al. Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks. Ann Rheum Dis 2005;64: 1557-62.
    • (2005) Ann Rheum Dis , vol.64 , pp. 1557-1562
    • Davis, J.C.1    van der Heijde, D.M.2    Braun, J.3
  • 10
    • 33745894976 scopus 로고    scopus 로고
    • Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial
    • van der Heijde D, Kivitz A, Schiff MH et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2006;54:2136-46.
    • (2006) Arthritis Rheum , vol.54 , pp. 2136-2146
    • van der Heijde, D.1    Kivitz, A.2    Schiff, M.H.3
  • 11
    • 44349177615 scopus 로고    scopus 로고
    • Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment
    • Briot K, Gossec L, Kolta S, Dougados M, Roux C. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment. J Rheumatol 2008;35:855-61.
    • (2008) J Rheumatol , vol.35 , pp. 855-861
    • Briot, K.1    Gossec, L.2    Kolta, S.3    Dougados, M.4    Roux, C.5
  • 12
    • 76649094260 scopus 로고    scopus 로고
    • Disease modification in ankylosing spondylitis
    • Maksymowych WP. Disease modification in ankylosing spondylitis. Nat Rev Rheumatol 2010;6:75-81.
    • (2010) Nat Rev Rheumatol , vol.6 , pp. 75-81
    • Maksymowych, W.P.1
  • 13
    • 54949113223 scopus 로고    scopus 로고
    • Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis
    • van der Heijde D, Landewe R, Baraliakos X et al. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 2008;58:3063-70.
    • (2008) Arthritis Rheum , vol.58 , pp. 3063-3070
    • van der Heijde, D.1    Landewe, R.2    Baraliakos, X.3
  • 14
    • 43949140512 scopus 로고    scopus 로고
    • Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept
    • van der Heijde D, Landewe R, Einstein S et al. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 2008;58:1324-31.
    • (2008) Arthritis Rheum , vol.58 , pp. 1324-1331
    • van der Heijde, D.1    Landewe, R.2    Einstein, S.3
  • 15
    • 73349110978 scopus 로고    scopus 로고
    • Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years
    • van der Heijde D, Salonen D, Weissman BN et al. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. Arthritis Res Ther 2009;11: R127.
    • (2009) Arthritis Res Ther , vol.11
    • van der Heijde, D.1    Salonen, D.2    Weissman, B.N.3
  • 16
    • 79959948424 scopus 로고    scopus 로고
    • Resolution of inflammation following treatment of ankylosing spondylitis is associated with new bone formation
    • Pedersen SJ, Chiowchanwisawakit P, Lambert RG, Ostergaard M, Maksymowych WP. Resolution of inflammation following treatment of ankylosing spondylitis is associated with new bone formation. J Rheumatol 2011; 38:1349-54.
    • (2011) J Rheumatol , vol.38 , pp. 1349-1354
    • Pedersen, S.J.1    Chiowchanwisawakit, P.2    Lambert, R.G.3    Ostergaard, M.4    Maksymowych, W.P.5
  • 17
    • 0026806990 scopus 로고
    • Appendicular and vertebral bone mass in ankylosing spondylitis A comparison of plain radiographs with single- and dual-photon absorptiometry and with quantitative computed tomography
    • Devogelaer JP, Maldague B, Malghem J, Nagant de Deuxchaisnes C. Appendicular and vertebral bone mass in ankylosing spondylitis. A comparison of plain radiographs with single- and dual-photon absorptiometry and with quantitative computed tomography. Arthritis Rheum 1992; 35:1062-7.
    • (1992) Arthritis Rheum , vol.35 , pp. 1062-1067
    • Devogelaer, J.P.1    Maldague, B.2    Malghem, J.3    Nagant de Deuxchaisnes, C.4
  • 18
    • 70349751396 scopus 로고    scopus 로고
    • Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes?
    • Kaya A, Ozgocmen S, Kamanli A, Ardicoglu O. Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes? Med Princ Pract 2009;18:470-6.
    • (2009) Med Princ Pract , vol.18 , pp. 470-476
    • Kaya, A.1    Ozgocmen, S.2    Kamanli, A.3    Ardicoglu, O.4
  • 19
    • 0021272107 scopus 로고
    • Evaluation of diagnostic criteria for ankylosing spondylitis A proposal for modification of the New York criteria
    • van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
    • (1984) Arthritis Rheum , vol.27 , pp. 361-368
    • van der Linden, S.1    Valkenburg, H.A.2    Cats, A.3
  • 20
    • 0029871201 scopus 로고    scopus 로고
    • Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS)
    • Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT. Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS). Br J Rheumatol 1996; 35:373-6.
    • (1996) Br J Rheumatol , vol.35 , pp. 373-376
    • Averns, H.L.1    Oxtoby, J.2    Taylor, H.G.3    Jones, P.W.4    Dziedzic, K.5    Dawes, P.T.6
  • 21
    • 4043058048 scopus 로고    scopus 로고
    • What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter
    • Wanders AJ, Landewe RB, Spoorenberg A et al. What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. Arthritis Rheum 2004; 50:2622-32.
    • (2004) Arthritis Rheum , vol.50 , pp. 2622-2632
    • Wanders, A.J.1    Landewe, R.B.2    Spoorenberg, A.3
  • 22
    • 0024810864 scopus 로고
    • Osteoporosis in early ankylosing spondylitis: a primary pathological event?
    • Will R, Palmer R, Bhalla AK, Ring F, Calin A. Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 1989;2:1483-5.
    • (1989) Lancet , vol.2 , pp. 1483-1485
    • Will, R.1    Palmer, R.2    Bhalla, A.K.3    Ring, F.4    Calin, A.5
  • 23
    • 0037379299 scopus 로고    scopus 로고
    • Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha
    • Allali F, Breban M, Porcher R, Maillefert JF, Dougados M, Roux C. Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha. Ann Rheum Dis 2003;62: 347-9.
    • (2003) Ann Rheum Dis , vol.62 , pp. 347-349
    • Allali, F.1    Breban, M.2    Porcher, R.3    Maillefert, J.F.4    Dougados, M.5    Roux, C.6
  • 24
    • 58849156499 scopus 로고    scopus 로고
    • Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis
    • Visvanathan S, van der Heijde D, Deodhar A et al. Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis. Ann Rheum Dis 2009; 68:175-82.
    • (2009) Ann Rheum Dis , vol.68 , pp. 175-182
    • Visvanathan, S.1    van der Heijde, D.2    Deodhar, A.3
  • 25
    • 0028239592 scopus 로고
    • Bone mineral density in ankylosing spondylitis DEXA comparison of control subjects with mild and advanced cases
    • Mullaji AB, Upadhyay SS, Ho EK. Bone mineral density in ankylosing spondylitis. DEXA comparison of control subjects with mild and advanced cases. J Bone Joint Surg Br 1994;76:660-5.
    • (1994) J Bone Joint Surg Br , vol.76 , pp. 660-665
    • Mullaji, A.B.1    Upadhyay, S.S.2    Ho, E.K.3
  • 26
    • 79952242241 scopus 로고    scopus 로고
    • The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis
    • Kang KY, Lee KY, Kwok SK et al. The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis. Joint Bone Spine 2011;78: 188-93.
    • (2011) Joint Bone Spine , vol.78 , pp. 188-193
    • Kang, K.Y.1    Lee, K.Y.2    Kwok, S.K.3
  • 27
    • 58249103888 scopus 로고    scopus 로고
    • Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation
    • Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, Ostergaard M, Lambert RG. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 2009;60:93-102.
    • (2009) Arthritis Rheum , vol.60 , pp. 93-102
    • Maksymowych, W.P.1    Chiowchanwisawakit, P.2    Clare, T.3    Pedersen, S.J.4    Ostergaard, M.5    Lambert, R.G.6
  • 28
    • 52249096602 scopus 로고    scopus 로고
    • The relationship between inflammation and new bone formation in patients with ankylosing spondylitis
    • Baraliakos X, Listing J, Rudwaleit M, Sieper J, Braun J. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther 2008;10:R104.
    • (2008) Arthritis Res Ther , vol.10
    • Baraliakos, X.1    Listing, J.2    Rudwaleit, M.3    Sieper, J.4    Braun, J.5
  • 29
    • 0035992959 scopus 로고    scopus 로고
    • How should clinicians manage osteoporosis in ankylosing spondylitis?
    • Bessant R, Keat A. How should clinicians manage osteoporosis in ankylosing spondylitis? J Rheumatol 2002;29:1511-9.
    • (2002) J Rheumatol , vol.29 , pp. 1511-1519
    • Bessant, R.1    Keat, A.2
  • 31
    • 22244456027 scopus 로고    scopus 로고
    • Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes
    • Karberg K, Zochling J, Sieper J, Felsenberg D, Braun J. Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 2005;32:1290-8.
    • (2005) J Rheumatol , vol.32 , pp. 1290-1298
    • Karberg, K.1    Zochling, J.2    Sieper, J.3    Felsenberg, D.4    Braun, J.5
  • 32
    • 63449120618 scopus 로고    scopus 로고
    • Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis
    • Ghozlani I, Ghazi M, Nouijai A et al. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 2009;44:772-6.
    • (2009) Bone , vol.44 , pp. 772-776
    • Ghozlani, I.1    Ghazi, M.2    Nouijai, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.